Clinical Research Study for Wet Age-Related Macular Degeneration (wAMD)
We are now enrolling participants for the LUGANO study, a clinical trial evaluating an investigational treatment (EYP-1901) compared with Eylea® for individuals with wet Age-Related Macular Degeneration (wAMD).
About the Study
- The study will last about 2 years.
- Participants will receive either the investigational treatment or the standard treatment, Eylea®, for comparison.
Who Can Join?
This study may be a fit if you:
- Are 50 years of age or older
- Have been diagnosed with wAMD
- Have not yet received prior treatment for wAMD in the study eye
Why Participate?
By joining, you may gain access to a new investigational treatment and contribute to research that could help improve care for people living with wAMD in the future.
If you or a loved one has been diagnosed with wet AMD and would like to learn more, please contact our research team to see if you qualify.
Interested? Contact Our Research Team
Glaucoma and Ocular Hypertension
-
Stent for the treatment of Primary Open Angle Glaucoma at the time of cataract surgery
Study description on clinicaltrials.gov
Diabetic Retinopathy
-
Oral medication for patients with moderate to severe Diabetic Retinopathy.
Study description on clinicaltrials.gov
Age Related Macular Degeneration
- Epidemiological study of AMD progression (non-interventional)
Pediatric
-
Dextenza for Inflammation and Pain Following Surgery for Pediatric Cataract.
Study description on clinicaltrials.gov
Past Clinical Trials
Eye Center of Northern Colorado is privileged to have worked with many drugs and devices that went on to gain FDA approval and are now used to treat patients every day. Some of these technologies include:
Cataract
- Acrysof Restor IOL
- Acrysof High Toric IOL
- IQ Vivity IOL
- IC-8 IOL
Glaucoma
- Glaukos iStent
- Xen Shunt
- Glaukos iStent Inject
- Glaukos G2-W
- Hydrus Microstent
- Rhopressa
- Simbrinza
- Glaukos iDose TR
- Elios System to Reduce Intraocular Pressure in Combination with Cataract Surgery
Myopia
- Pediatric Myopia Ophthalmic Solution SYD-101
- Progression of Myopia in Pediatric Patients using Atropine Sulphate 0.01% (OT-101)
Presbyopia
- Kamra Inlay
Retina
- Susvimo for Wet Age-related Macular Degeneration
- Diabetic Retinopathy OPL-0401
- Macular Edima Port Delivery System with Lucentis (Pagoda)
- Wet AMD Port Delivery System with Lucentis (Portal)
Dry Eye
- Tyrvaya Nasal Spray
Keratoconus
- Oxygen Enriched Cross-Linking
Inflammation
- Inveltys
- TobraDex
- Nevanac
